Introduction
The process of nucleoside influx into cells has been shown to be mediated by a mechanism of facilitated diffusion both in erythrocytes and cultured cells (Plagemann & Wohlhueter, 1980; Paterson et al., 1981 ; Young & Jarvis, 1983; Paul et al., 1975; Cass et al., 1974; Jarvis & Young, 1980; Lauzon et al., 1977) . Recently, a concentrative carrier-mediated transport of nucleosides has also been found in cells directly isolated from normal tissues (Spector, 1980 (Spector, , 1982 (Spector, , 1985 Schwenk et al., 1984; Jakobs & Paterson, 1986; Darnowski et al., 1987) . Passive diffusion does not contribute significantly to nucleoside permeation under physiological conditions (Plagemann et al., 1988) , an observation consistent with the hydrophilic nature of the nucleoside molecule.
The properties of cell membranes can change quite drastically when cells are infected with viruses, leading to structural alterations of membranes themselves and to modifications in the cells' electric potential (Fritz & Nahmias, 1972; Carrasco & Esteban, 1982; Spear et al., 1970; Farnham & Epstein, 1963; Garry et al., 1979; Francoeur & Stanners, 1978) . Moreover, the occurrence of membrane leakiness has been described to account for the entry of normally impermeant metabolites (Carrasco, 1977 (Carrasco, , 1978 Carrasco & Smith, 1976) . Cell leakiness has a number of practical implications, particularly with respect to some aspects of drug metabolism under conditions of viral infection and the use of impermeant compounds as selective antiviral agents (Lacal & Carrasco, 1983; Benedetto et al., 1980) . It is reasonable to assume that virus infection and leakiness, in particular, could also affect the uptake of those substances such as nucleosides, which normally only permeate through a transporter. Changes in the permeation of nucleosides could be relevant to the effectiveness of antiviral therapy, which is currently based on nucleoside analogues. The limited evidence that is available suggests a reduced nucleoside transport in cells infected with togaviruses or picornaviruses (Genty, 1975; Castrillo & Carrasco, 1986) . However, the majority of these experiments were performed using techniques (filtration and washing) that do not permit measurement of the initial rates of solute influx. With these methods, the contributions from intracellular nucleoside metabolism and redistribution between intraceUular and extraceUular compartments are combined to prevent evaluation of effects on the uptake process. To gain further insight into the effects produced by viral infection on cell nucleoside permeation we have undertaken experiments on the transport of thymidine (TdR) by HeLa $3 cells infected with herpes simplex virus type 1 (HSV-1). TdR was used 0000-9264 © 1990 SGM because most antiviral agents are related to it (Dolin, 1985) and HSV-1 was selected as the experimental model because of its sensitivity to nucleoside analogues (De Clercq, 1982 , 1989 .
Methods

Radioisotopes and compounds.
[14C]Sucrose (>540 mCi/mmol), [3H]TdR (14.2 Ci/mmol), tritiated water (1 Ci/ml) and inulin [14C]carboxylic acid (2 to 10 mCi/mmol) were purchased from Amersham.
[3H]NBMPR (4 Ci/mmol; 6-[(4-nitrobenzyl)thio]-9-fl-Dribofuranosylpurine) was purchased from Maravek Biochemicals. NBMPR and dipyridamole were from Aldrich and Sigma, respectively. All reagents used in our experiments were AnalaR grade.
Cells and culture conditions. All experiments reported in this paper were performed using HeLa $3 cells, a cell line adapted to growth in suspension. These cells allowed the measurement of the initial rates of nucleoside influx, an approach not feasible with adherent cells. HeLa S3 cells were normally grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% (v/v) foetal calf serum (FCS), 2 mMglutamine, 20 mM-HEPES and antibiotics. Cells were cultured in 25 cm 2 diameter roller bottles at 3.5 r.p.m, in a moist atmosphere of air and 5% CO2, starting with 5 x 104 cells/ml.
Virus infection. HeLa $3 cells were infected with the wild-type (wt) strain of HSV-1 (Pall et al., 1988 (Pall et al., , 1989 Pal6 & Biasolo, 1988) at an m.o.i, of 20 p.f.u./cell. In some control experiments HeLa $3 cells were also infected with the HSV-1 thymidine kinase (TK)-deficient strains R100 (Palfi et al., 1988 (Palfi et al., , 1989 and CL 101-TK 43 (Summers et al., 1983) , which multiplied at the same rate in this cell line, as shown by one-step growth measurements. During the adsorption period (1 h) bottles were rotated at 1.5 r.p.m. Cells were then sedimented and resuspended in DMEM with 2% FCS in new bottles, which were again rotated at 3.5 r.p.m. At various intervals after infection cells were harvested and used for studying TdR uptake, titration of NBMPR binding sites and protein synthesis. At the end of each experiment virus growth was measured by titrating the yields of infectious progeny by plaque titrations on susceptible Vero cells (Pahi et aL, 1984) .
Determination of protein synthesis inhibition. HeLa $3 cells were infected with the wt strain at an m.o.i, of 20 p.f.u./cell and labelled with L-[3sS]methionine (> 1000 Ci/mmol) for each successive 2 h interval during the period from 0 to 8 h post-infection (p.i.). Cultures were labelled in DMEM containing one-tenth the normal amount of Lmethionine and 0.5% dialysed FCS. After the labelling period cells were lysed in Laemmli solution and the lysates separated by 12% SDS-PAGE. Following the electrophoretic run, gels were fixed in a 15% TCA and 30% methanol solution, dried and the gel films scanned with an AMBIS automated beta scanning system (Automated Microbiology Systems) to evaluate the relative amount of radioactivity incorporated in each protein band.
Determination ofthymidine uptake. Initial rates of thymidine uptake were determined according to the method of Young & Jarvis (1983) , as described in detail below. Solutions of the nucleoside were prepared that contained a mixture of unlabelled and radioactive TdR (in a 300 to 1 molar ratio). Equal volumes (100 ~tl) of TdR and cell suspension (5 x 106 cells/ml) were simultaneously mixed, using a dual syringe (Young & Jarvis, 1983) , and dispensed in a series of 500 Ixl microhaemocytohaeter (microfuge) tubes placed in an Eppendorf centrifuge 5414. These ~ubes contained 50 Ixl of a (20% w/v) solution of TCA overlaid with 100 ~tl of a mixture of silicone oil and paraffin (density 1.13 g/ml). After various periods of time (0 to 180 s) the cell suspensions were sedimented by centrifugation (12000 g for 30 s) through the oil-paraffin mixture into TCA. The microfuge tubes were frozen in dry ice and ethanol and the tube bottom containing the cell pellet in TCA was sliced off. The intracellular incorporation of TdR was measured in a liquid scintillation spectrometer (LKB 1214 RackBeta).
For inhibition experiments with dipyridamole HeLa $3 cells were preincubated at 21 °C for 20 min with the inhibitor.
Sucrose uptake and calculation of intracellular and extracellular space. HeLa $3 cells (5 x 106 cells/ml) were incubated for 2 min with increasing concentrations of [l~C]sucrose (from 0-1 to 1 ktCi), tritiated water (from 0.1 to 1 ~tCi) and [14C]inulin (from 0.1 to 1 p.Ci). At the end of the incubation cells were centrifuged through the oil-paraffin mixture, as previously described. Intracellular volume was calculated by subtracting the inulin space from the water space (Belt, 1983) . Sucrose permeation was considered to have occurred when the space occupied by this molecule exceeded the extracellular space, as measured by radioactive inulin. 
Results
Inhibition of protein synthesis
After virus infection, synthesis of cellular polypeptides declined progressively from 2 h onwards, as depicted in Fig. 1 and confirmed by a computerized radiometric analysis of radioactive polyacrylamide gels (not shown). A drastic inhibition of the host cell protein synthesis in HSV-l-infected cells began from 4 h p.i., at which time cells were still intact, as judged by trypan blue exclusion. Although there was an almost 100~o reduction in the synthesis of some cellular proteins, complete inhibition was not produced, even at 8 h p.i. Actin seemed to be the least affected of the whole set of cellular proteins.
Transport studies
Zero-trans flux experiments were performed at 1, 4, 8 and 24 h p.i. At 24 h p.i. the majority of cells could not be sedimented through the silicone oil mixture, but remained at the interface between the medium and the lipophilic solvent. The uptake process was therefore only measured at intervals from 0 to 8 h p.i. In both infected and uninfected HeLa $3 cells the process of TdR influx increased linearly in the period from 2 to 20 s after addition of the nucleoside to the incubation medium. Thereafter the rate of uptake declined, reaching a plateau after about 40 s (Fig. 2a) . Addition of a large excess of unlabelled TdR abolished the linear uptake that occurred from 2 s onwards, but did not prevent the very rapid increase in radioactivity observed within the first 2 s. Therefore, it seems likely that a non-specific T d R association with the plasma membrane, rather than a carrier-mediated uptake, was responsible for the increase in radioactivity measured during the initial 2 s. Accordingly, initial rates of uptake were determined as the difference between the uptake at 15 and 5 s. The rates of T d R influx are expressed as the change in the intracellular concentration of nucleoside (molarity) per s. As shown in Fig. 2(b) a threefold increase in the influx rate occurred after 8 h of viral infection, although the increase in T d R influx was already evident as early as 1 h p.i.
Influx of sucrose
The entry of sucrose was measured in order to determine whether infected cells became leaky to this normally 
Titration of NBMPR binding sites
The results of N B M P R binding to uninfected H e L a cells and cells 8 h after virus infection are presented in Fig.  3 x l0 s and 8-9 x 105 per cell in uninfected and infected cells, respectively). Preliminary experiments had indicated that the maximal inhibition of TdR uptake by NBMPR was 65 ~o, an observation that is consistent with previous results (Plagemann et al., 1988) . The curvature of the binding isotherms suggests the presence of at least two independent binding sites with different affinities for NBMPR. Dissociation constants for NBMPR, evaluated from binding isotherms by computer fitting, as previously described (Wohlhueter et al., 1983) , indicated that the overall affinity of NBMPR for the transporter was not changed significantly by viral infection (Kd for the high affinity site was 1.3 x 10 -1° and 1.4 x 10 -1° M in uninfected and infected cells, respectively). Consistent with the exclusive presence of a carriermediated influx, the uptake process reached a plateau in uninfected cells. In infected cells the transport kinetics underwent a dramatic change and the saturation curve did not reach a plateau. This alteration in the uptake process was evident as early as 1 h p.i. and was the major uptake process by 8 h p.i. Kinetic parameters of the influx process were determined by computer fitting (Roos & Pfleger, 1972) (Roos & Pfleger, 1972) .
Saturation kinetics experiments
Inhibition studies
Further evidence for development of a carrier-independent entry of TdR was obtained by inhibition experiments with dipyridamole. This inhibitor specifically prevents the carrier-mediated uptake of nucleosides Paterson et al., 1980; Eilam & Cabantchik, 1977; Aaronow et al., 1986) , whereas the passive diffusion component should be unaffected. Dipyridamole was preferred to NBMPR for these experiments, since HeLa cells proved to be more sensitive to the former inhibitor (maximal inhibition was 90% at 1 IxM-dipyridamole, as previously observed; Paterson et al., 1980) . Fig. 5(a) shows that 100 nMdipyridamole produced 67% inhibition of nucleoside uptake in uninfected cells. At progressively later times after virus infection, the proportion of uptake that was inhibited by dipyridamole decreased, indicating that the dipyridamole-sensitive component of the total uptake was becoming less and less important as the viral infection progressed. uptake was relatively resistant to the inhibitor and residual uptake was almost linear, again indicating the presence of a major contribution from a passive diffusion process.
Discussion
The process of virus infection produces gradual alterations of the permeability and transport properties of the G. Pal~ and others cell membrane. For example, certain molecules that do not enter the cell under normal conditions can cross the membrane barrier after viral infection. Conversely, some molecules that are actively transported into normal cells are no longer accumulated in infected cells (Lacal & Carrasco, 1983) . The exact consequences of viral infection on the entry of nucleosides into cells have not yet been elucidated. In the present paper we have shown that the transport of TdR in HeLa $3 cells is greatly affected by infection with HSV-1. The first important observation is the increase in the net rate of TdR uptake that occurs after infection. As the initial rates of TdR influx were always measured, this phenomenon is probably a direct effect of modifications to the properties of the membrane and not secondary to intracellular changes in the activity of enzymes encoded by either the cell or the virus, such as nucleoside kinases, phosphorylases or phosphatases. Similar results were obtained using the HSV-1 TK-deficient strains R100 and CL 101-TK 43, or after depleting the cells of ATP by arsenate treatment Wohlhueter et al., 1979) (not shown).
After infection, as illustrated in Fig. 4 , passive diffusion was gradually superimposed upon facilitated transport. Accompanying the increase of passive diffusion of TdR is the entry of sucrose, a normally impermeant molecule with approximately the same molecular size as the nucleoside. Inulin (6000K), a much larger polymer, is still excluded by the intracellular compartment under the same conditions. The increase in passive diffusion caused by HSV-1 infection correlates temporally with the virus-induced inhibition of cell protein synthesis.
Saturation kinetics experiments provided evidence that the affinity of the nucleoside transporter for thymidine is not significantly changed by viral infection and that the maximum velocity of the carrier-mediated transport process is unaltered. This latter result is consistent with the observation that the total number of transporter molecules, as deduced from the maximum value of NBMPR binding, is not decreased in infected cells. These results suggest that the half-life of the transporter is quite long (certainly more than 8 h) and that the facilitated diffusion route is still operating in HSV-infected cells.
Our results on the transport of TdR in HSV-l-infected HeLa $3 cells are somewhat at variance with data previously reported by other authors (Genty, 1975; Castrillo & Carrasco, 1986) , showing a decrease in total nucleoside uptake after virus infection. However, these studies were carried out with different viruses (vesicular stomatitis virus and encephalomyocarditis virus). In addition, the experimental conditions were such that actual differences in transport could not be measured, since uptake was assessed from data on incorporation and variation of nucleoside pools at times longer than 1 min.
Influx of normally impermeant substances, especially low Mr aminoglycosides, has previously been reported in virus-infected cells (Lacal & Carrasco, 1983; Benedetto et al., 1980) . This property led to the suggestion of a new approach to an antiviral chemotherapy with substances that are made permeant by virus infection. For those antiviral nucleosides which are transported via the facilitated diffusion system, it could be suggested that prior blockade with dipyridamole would prevent entry of cytotoxic agents into uninfected cells, but allow entry into the infected cell population.
Further investigation into the nature of the damage produced by HSV-1 infection upon cell structures that are directly or indirectly involved in transport functions is certainly warranted. Such information may bear a potential relationship to viral pathogenicity and may also contribute to dissection of some functional properties of carriers whose structure has not been defined.
